Daley Clinical Research Consulting Inc is categorized under Business Consultants in Northampton, MA and active since 2009.
Daley Clinical Research Consulting Inc was established in 2009, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 541618 by the NAICS.
If you are seeking more information, feel free to contact Charles Daley at the company’s single location by writing to 34 Warburton Way, Northampton, Massachusetts MA 01060 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Daley Clinical Research Consulting Inc |
| Contact Person: | Charles Daley |
| Address: | 34 Warburton Way, Northampton, Massachusetts 01060 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 541618 |
| Share This Business: |
Daley Clinical Research Consulting Inc was started in 2009 to provide professional Business Consultants under the SIC code 8748 and NAICS code 541618. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Charles Daley for inquiries that concern Daley Clinical Research Consulting Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Daley Clinical Research Consulting Inc can be found at the coordinates as well as the street address 34 Warburton Way in Northampton, Massachusetts 01060.
For its online presence, you may visit Daley Clinical Research Consulting Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.